Section 1 - COMPONENTS OF IDEAL SCI CARE SYSTEM

• A - PREHOSPITAL AND EMERGENCY

  • A.1 - EXTRICATION & TRANSPORTATION OF PATIENTS WITH ACUTE TRAUMATIC SPINE INJURIES
  • A.2 - ASSESSMENT AND MANAGEMENT IN PREHOSPITAL SETTINGS FOR SPINAL INJURY
  • A.3 - ASSESSMENT FOR THORACIC OR LUMBOSACRAL SPINE INJURY
  • A.4 - WHEN TO CARRY OUT OR MAINTAIN FULL IN-LINE SPINAL IMMOBILIZATION
  • A.5 - HOW TO CARRY OUT FULL IN-LINE SPINAL IMMOBILIZATION
  • A.6 - RECEIVING INFORMATION IN HOSPITAL SETTINGS
  • A.7 - EMERGENCY DEPARTMENT ASSESSMENT AND MANAGEMENT
  • A.8 - NEUROLOGICAL EXAMINATION FOLLOWING ACUTE CERVICAL SCI
  • A.9 - RECORDING INFORMATION IN HOSPITAL SETTINGS
  • A.10 - TIMING OF DECOMPRESSIVE SURGERY (<=24 HOURS AFTER INJURY) IN PATIENTS WITH ACUTE SPINAL CORD INJURY
  • A.11 - PROVIDING INFORMATION ON TRANSFER FROM AN EMERGENCY DEPARTMENT
  • A.12 - COMMUNICATION WITH TERTIARY SERVICES

• B - EDUCATION AND SUPPORT OF INDIVIDUALS WITH SCI AND THEIR FAMILIES ACROSS THE CONTINUUM

  • B.1 - PROVIDING INFORMATION TO PATIENTS AND THEIR FAMILY MEMBERS
  • B.2 - INFORMATION AND SUPPORT FOR PATIENTS, FAMILY MEMBERS AND CAREGIVERS
  • B.3 - EDUCATION FOR INDIVIDUALS WITH SCI AND CAREGIVERS – AUTONOMIC DYSREFLEXIA
  • B.4 - EDUCATION FOR INDIVIDUALS WITH SCI AND CAREGIVERS – BOWEL
  • B.5 - SUPPORT FOR VULNERABLE ADULTS

• C - CROSS CONTINUUM EDUCATION OF CLINICIANS AND STAFF WORKING WITH INDIVIDUALS WITH SCI

  • C.1 - TRAINING AND EDUCATION OF HEALTHCARE PROFESSIONALS – PRESSURE INJURY
  • C.2 - TRAINING AND EDUCATION OF HEALTHCARE PROFESSIONALS – SEXUAL HEALTH
  • C.3 - TRAINING AND EDUCATION OF HEALTHCARE PROFESSIONALS – EMOTIONAL WELL-BEING
  • C.4 - TRAINING AND EDUCATION OF HEALTHCARE PROFESSIONALS – TELEREHABILITATION

• D - DIAGNOSTIC IMAGING

  • D.1 - GENERAL RECOMMENDATIONS
  • D.2 - DIAGNOSTIC IMAGING - SUSPECTED SPINAL CORD OR CERVICAL COLUMN INJURY
  • D.3 - DIAGNOSTIC IMAGING - SUSPECTED THORACIC OR LUMBOSACRAL COLUMN INJURY ONLY
  • D.4 - DIAGNOSTIC OF VERTEBRAL ARTERY INJURIES FOLLOWING NON-PENETRATING CERVICAL TRAUMA
  • D.5 - RADIOGRAPHIC ASSESSMENT IN AWAKE, SYMPTOMATIC PATIENT
  • D.6 - RADIOGRAPHIC ASSESSMENT IN OBTUNDED OR UNEVALUABLE PATIENT

• E - EARLY ACUTE CARE

  • E.1 - EARLY MEDICAL MANAGEMENT
  • E.2 - ROLE OF THE REGISTERED DIETITIAN
  • E.3 - NUTRITION ASSESSMENT: ENERGY NEEDS IN THE ACUTE PHASE
  • E.4 - PREVENTION - PREVENTING PRESSURE INJURIES DURING THE ACUTE CARE PHASE

• F - SPECIALIZED REHAB

  • F.1 - GENERAL RECOMMENDATIONS
  • F.2 - FUNCTIONAL OUTCOME ASSESSMENT FOLLOWING ACUTE CERVICAL SCI
  • F.3 - COMMUNITY CARE

• G - COMMUNITY-BASED REHABILITATION

  • G.1 - GENERAL RECOMMENDATIONS
  • G.2 - COMMUNITY CARE

• H - VOCATIONAL REHABILITATION

  • H.1

• I - COMPREHENSIVE HEALTH & WELLNESS

  • I.1

Section 2 - MANAGEMENT OF SCI COMPLICATIONS

• J - AUTONOMIC DYSREFLEXIA (AD)

  • J.1 - BLOOD PRESSURE FOLLOWING SPINAL CORD INJURY
  • J.2 - MANAGEMENT OF AUTONOMIC DYSREFLEXIA
  • J.3 - AUTONOMIC DYSREFLEXIA: SEXUALITY (RECOMMENDATIONS FOR SEXUAL ACTIVITY IN THE HOME SETTING)
  • J.4 - AUTONOMIC DYSREFLEXIA AND CYSTOSCOPIC (TRANSURETHRAL AND SUPRAPUBIC) UROLOGICAL PROCEDURES AND SPERM RETRIEVAL PROCEDURES PERFORMED IN THE CLINIC SETTING
  • J.5 - AUTONOMIC DYSREFLEXIA IN PREGNANCY, LABOR AND DELIVERY, AND THE POSTPARTUM PERIOD
  • J.6 - INDUCED AUTONOMIC DYSREFLEXIA (“BOOSTING”)
  • J.7 - ORTHOSTATIC HYPOTENSION
  • J.8 - THERMODYSREGULATION - HYPOTHERMIA (CORE TEMPERATURE LESS THAN 35.0°C/95OF)
  • J.9 - THERMODYSREGULATION - HYPERTHERMIA (CORE TEMPERATURE MORE THAN 37.8°C/100OF)
  • J.10 - HYPERHIDROSIS

• K - BLADDER FUNCTION

  • K.1 - HISTORY
  • K.2 - PHYSICAL
  • K.3 - VOIDING DIARY
  • K.4 - URODYNAMICS
  • K.5 - URINARY TRACT INFECTION (UTI)
  • K.6 - BLADDER MANAGEMENT
  • K.7 - CATHETERS
  • K.8 - NON-PHARMACOLOGICAL THERAPIES TO ENHANCE BLADDER FUNCTION
  • K.9 - PHARMACOLOGICAL THERAPY TO ENHANCE BLADDER FUNCTION
  • K.10 - NEUROGENIC DETRUSOR OVERACTIVITY
  • K.11 - INTRAVESICAL BOTULINUM TOXIN INJECTIONS
  • K.12 - ROUTINE URINARY TRACT SURVEILLANCE
  • K.13 - UROLOGY CONSULTATION
  • K.14 - POST-VOID-RESIDUAL
  • K.15 - STONES & HYDRONEPHROSIS
  • K.16 - CANCER SCREENING

• L - BONE HEALTH

  • L.1 - ASSESSMENT OF FRACTURE RISK
  • L.2 - DXA TESTING
  • L.3 - PREVENTION OF OSTEOPOROSIS
  • L.4 - TREATMENT OF OSTEOPOROSIS

• M - BOWEL

  • M.1 - AIMS OF NEUROGENIC BOWEL MANAGEMENT
  • M.2 - ASSESSMENT OF NEUROGENIC BOWEL DYSFUNCTION
  • M.3 - BASIC BOWEL MANAGEMENT (BBM)
  • M.4 - ADAPTIVE EQUIPMENT
  • M.5 - DIET, SUPPLEMENTS, FIBER, FLUIDS, AND PROBIOTICS
  • M.6 - ORAL MEDICATIONS
  • M.7 - USE OF SUPPOSITORIES, ENEMAS, AND IRRIGATION
  • M.8 - IMPACT OF POSTURE AND ACTIVITY ON NEUROGENIC BOWEL DYSFUNCTION
  • M.9 - USE OF FUNCTIONAL ELECTRICAL STIMULATION
  • M.10 - SURGICAL INTERVENTION TO MANAGE NEUROGENIC BOWEL DYSFUNCTION
  • M.11 - MANAGING MEDICAL COMPLICATIONS OF NEUROGENIC BOWEL DYSFUNCTION
  • M.12 - ASSESSING INDEPENDENT USE OF TOILET FOR BOWEL CARE
  • M.13 - EDUCATION FOR INDIVIDUALS WITH SCI AND CAREGIVERS
  • M.14 - PSYCHOSOCIAL ASPECTS OF NEUROGENIC BOWEL DISEASE

• N - CARDIOMETABOLIC

  • N.1 - MANAGEMENT OF CARDIOMETABOLIC DISEASE RISK COMPONENTS AFTER SCI - LIFESTYLE INTERVENTION (NUTRITION AND PHYSICAL ACTIVITY)
  • N.2 - EXERCISE TO IMPROVE FITNESS AND CARDIOMETABOLIC HEALTH
  • N.3 - NUTRITION ASSESSMENT AND MANAGEMENT
  • N.4 - NUTRITION ASSESSMENT FOR PREVENTION AND TREATMENT OF OVERWEIGHT AND OBESITY
  • N.5 - OBESITY
  • N.6 - hypertension
  • N.7 - PHARMACOTHERAPY FOR HYPERTENSION
  • N.8 - IMPAIRED FASTING GLUCOSE, PRE-DIABETES, AND DIABETES
  • N.9 - DYSLIPIDEMIA
  • N.10 - PHARMACOTHERAPY FOR DYSLIPIDEMIA
  • N.11 - DIABETES- PHARMACOTHERAPY FOR DYSGLYCEMIA, TYPE-2 PRE-DIABETES & TYPE-2 DIABETES
  • N.12 - BARIATRIC SURGERY FOR CARDIOMETABOLIC DISEASE RISK
  • N.13 - NUTRITIONAL SUPPORT AFTER SCI

• O - EMOTIONAL WELL-BEING

  • O.1 - SCREENING, ASSESSMENT AND TREATMENT
  • O.2 - DIAGNOSIS-SPECIFIC DISORDERS: ANXIETY DISORDERS
  • O.3 - DIAGNOSIS-SPECIFIC DISORDERS: MAJOR DEPRESSIVE DISORDER (MDD)
  • O.4 - DIAGNOSIS-SPECIFIC DISORDERS: SUBSTANCE USE DISORDERS
  • O.5 - POSTTRAUMATIC STRESS DISORDER (PTSD) AND ACUTE STRESS DISORDER (ASD)
  • O.6 - SUICIDE

• P - NEUROPATHIC PAIN

  • P.1 - PAIN ASSOCIATED WITH SCI
  • P.2 - SCREENING FOR NEUROPATHIC PAIN
  • P.3 - DIAGNOSIS OF NEUROPATHIC PAIN
  • P.4 - DELIVERY OF CARE FOR NEUROPATHIC PAIN
  • P.5 - RECOMMENDATIONS FOR NEUROPATHIC PAIN TREATMENT – FIRST-LINE THERAPY
  • P.6 - RECOMMENDATIONS FOR NEUROPATHIC PAIN TREATMENT – SECOND-LINE THERAPY
  • P.7 - RECOMMENDATIONS FOR NEUROPATHIC PAIN TREATMENT – THIRD-LINE THERAPY
  • P.8 - RECOMMENDATIONS FOR NEUROPATHIC PAIN TREATMENT – FOURTH-LINE THERAPY
  • P.9 - NON-PHARMACOLOGICAL THERAPIES

• Q - RESPIRATORY

  • Q.1 - LUNG VOLUME RECRUITMENT
  • Q.2 - ABDOMINAL BINDER AND ABDOMINAL MUSCLE STIMULATION
  • Q.3 - PHARMACOLOGICAL AGENTS FOR RESPIRATORY FUNCTION
  • Q.4 - RESPIRATORY MUSCLE TRAINING
  • Q.5 - HOME MECHANICAL VENTILATION

• R - SEXUAL HEALTH & RELATIONSHIPS

  • R.1 - INTRODUCTORY RECOMMENDATIONS
  • R.2 - EDUCATION
  • R.3 - RELATIONSHIPS
  • R.4 - SEXUAL HISTORY & ASSESSMENT
  • R.5 - OPTIMIZING SEXUAL WELL-BEING/POSITIVE BODY IMAGE AND SENSUALITY
  • R.6 - PHYSICAL AND PRACTICAL CONSIDERATIONS – BLADDER
  • R.7 - PHYSICAL AND PRACTICAL CONSIDERATIONS – BOWEL
  • R.8 - PHYSICAL AND PRACTICAL CONSIDERATIONS – SENSATION
  • R.9 - PHYSICAL AND PRACTICAL CONSIDERATIONS – MOBILITY, SPASTICITY AND CONTRACTURES
  • R.10 - PHYSICAL AND PRACTICAL CONSIDERATIONS – SKIN INTEGRITY
  • R.11 - PHYSICAL AND PRACTICAL CONSIDERATIONS – AUTONOMIC DYSREFLEXIA
  • R.12 - TREATMENT OF SEXUAL DYSFUNCTION
  • R.13 - FERTILITY
  • R.14 - CONTRACEPTION
  • R.15 - PREGNANCY

• S - SKIN INTEGRITY

  • S.1 - PREVENTION - PRESSURE INJURY PREVENTION AND THE INTERPROFESSIONAL TEAM
  • S.2 - PREVENTION – EDUCATION
  • S.3 - OPTIMIZING MOBILITY TO REDUCE PRESSURE INJURY RISK
  • S.4 - PREVENTION STRATEGIES ACROSS THE CONTINUUM OF CARE
  • S.5 - PRESSURE REDISTRIBUTION AND SUPPORT SURFACES – SUPPORT SURFACES FOR WHEELCHAIRS AND OTHER SEATING
  • S.6 - RECUMBENT POSITIONING
  • S.7 - SUPPORT SURFACES (MATTRESS)
  • S.8 - SITTING SUPPORT SURFACES INCLUDING WHEELCHAIRS (SEAT CUSHIONS AND BACKREST)
  • S.9 - OTHER SEATING
  • S.10 - RISK & RISK ASSESSMENT
  • S.11 - NUTRITIONAL OPTIMIZATION FOR THE INDIVIDUAL WITH A PRESSURE INJURY
  • S.12 - ASSESSMENT OF THE INDIVIDUAL WITH A PRESSURE INJURY
  • S.13 - PATIENT ASSESSMENT - ASSESSMENT AND REASSESSMENT OF THE PRESSURE INJURY
  • S.14 - PATIENT ASSESSMENT - ASSESSMENT USING THE 24-HOUR APPROACH TO PRESSURE MANAGEMENT
  • S.15 - REASSESSMENT
  • S.16 - PRINCIPLES OF TREATMENT OF A PRESSURE INJURY
  • S.17 - CREATING A PHYSIOLOGIC WOUND ENVIRONMENT
  • S.18 - DEBRIDEMENT
  • S.19 - WOUND CARE DRESSING AND MANAGEMENT
  • S.20 - ELECTRICAL STIMULATION
  • S.21 - SURGICAL TREATMENT
  • S.22 - OPTIMIZATION OF HEMATOLOGIC AND BIOCHEMICAL PARAMETERS FOR PRESSURE INJURY HEALING
  • S.23 - TRAINING AND EDUCATION OF HEALTHCARE PROFESSIONALS

• T - VTE PROPHYLAXIS

  • T.1 - PROPHYLAXIS OF DEEP-VEIN THROMBOSIS (DVT)
  • T.2 - ANTICOAGULANT METHODS OF THROMBOPROPHYLAXIS - SCREENING PATIENTS FOR ASYMPTOMATIC DEEP-VEIN THROMBOSIS
  • T.3 - DIAGNOSIS
  • T.4 - ANTICOAGULANT METHODS OF THROMBOPROPHYLAXIS - DURING THE REHABILITATION PHASE
  • T.5 - THROMBOPROPHYLAXIS IN CHRONIC SCI PATIENTS WHO ARE REHOSPITALIZED

• U - WHEELED MOBILITY

  • U.1

• V - ACTIVITY-BASED THERAPY

  • V.1

• W - MOBILITY AND WALKING

  • W.1

• X - UPPER LIMB

  • X.1